Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-379,627 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
N/A
277,635 Added 272.21%
379,627 $6.67 Million
Q2 2021

Aug 11, 2021

SELL
N/A
-81,309 Reduced 44.36%
101,992 $989,000
Q1 2021

May 17, 2021

SELL
N/A
-180,805 Reduced 49.66%
183,301 $1.97 Million
Q4 2020

Feb 16, 2021

SELL
N/A
-9,914 Reduced 2.65%
364,106 $5.36 Million
Q3 2020

Nov 16, 2020

BUY
N/A
69,704 Added 22.91%
374,020 $5.32 Million
Q2 2020

Aug 14, 2020

BUY
N/A
193,430 Added 174.44%
304,316 $2.46 Million
Q1 2020

May 15, 2020

BUY
N/A
110,886 New
110,886 $448,000
Q2 2019

Aug 14, 2019

SELL
N/A
-98,673 Closed
0 $0
Q1 2019

May 15, 2019

BUY
N/A
98,673 New
98,673 $65,000

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.